• Realm surrenders after back-to-back clinical defeats fiercebiotech
    September 18, 2018
    Faced with a pair of phase 2 failures, Realm Therapeutics has abandoned the platform that underlies all its drug development programs and engaged advisers to look into a possible sale...
PharmaSources Customer Service